Product Information
TOPIRAMATE 100 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0567 per EA under NDC 68462010905. Its NADAC has been published 305 times since Dec 2, 2020.
FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462010905
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA077627FDA Approved
3/27/2009
TE Code
AB
On Market Since
3/27/2009
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 100 MG TABLET has been published 305 times since Dec 2, 2020, and over the history we have for it it has declined 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0567 per EA |
|---|---|
| All-time high | $0.0711 (Dec 16, 2020) |
| All-time low | $0.0486 (Nov 20, 2024) |
| 52-week high | $0.0628 |
| 52-week low | $0.0550 |
| Median price | $0.0642 |
| Average price | $0.0636 |
| Largest weekly change | +33.1% (Aug 21, 2024) |
| Weeks tracked | 305 |
| Tracking since | Dec 2, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Topiramate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 100 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0567 per EA (NDC 68462010905), effective Sep 30, 2026.
How has the price of TOPIRAMATE 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 100 MG TABLET has declined 20.3%. It has been tracked across 305 weekly CMS publications since Dec 2, 2020.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 100 MG TABLET?
Since Dec 2, 2020, the NADAC for TOPIRAMATE 100 MG TABLET has ranged from a low of $0.0486 (Nov 20, 2024) to a high of $0.0711 (Dec 16, 2020), with a median of $0.0642 per EA.
Are there cheaper alternatives to TOPIRAMATE 100 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 100 MG TABLET, is $0.0550 per EA — about 3% below TOPIRAMATE 100 MG TABLET.
Who manufactures TOPIRAMATE 100 MG TABLET?
TOPIRAMATE 100 MG TABLET (NDC 68462010905) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.